Personalized treatment strategies are crucial in managing lung cancer brain metastases, integrating targeted therapies and immunotherapies for improved outcomes.
Stereotactic radiosurgery and whole-brain radiation therapy remain important, but their roles are evolving with new systemic therapies.
Multidisciplinary approaches optimize treatment plans by considering genetic mutations, patient performance status, and metastases extent.
Ongoing research aims to refine strategies for better survival and quality of life in patients with lung cancer brain metastases.
SHOW MORE
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.